[Answered] Code for obliteration of carotid-cavernous fistula by dissection within cavernous sinus. A) 61613 ...

This topic contains a solution. Click here to go to the answer

Author Question: Code for obliteration of carotid-cavernous fistula by dissection within cavernous sinus. A) 61613 ... (Read 34 times)

Coya19@aol.com

Hero Member
Posts: 601

on: Jun 27, 2018

Code for obliteration of carotid-cavernous fistula by dissection within cavernous sinus.

A) 61613
B) 61591
C) 64716
D) 63035

Question 2

Code 50660 for ureterectomy with a bladder cuff.

A) True
B) False

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

14vl19

Sr. Member
Posts: 310

Reply #1 on: Jun 27, 2018

Answer to Question 1

Answer: A

Answer to Question 2

Answer: B

Coya19@aol.com

Member
Posts: 601

Reply 2 on: Jun 27, 2018

Gracias!

carlsona147

Member
Posts: 341

Reply 3 on: Yesterday

YES! Correct, THANKS for helping me on my review

« previous next »

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Drug abusers experience the following scenario: The pleasure given by their drug (or drugs) of choice is so strong that it is difficult to eradicate even after years of staying away from the substances involved. Certain triggers may cause a drug abuser to relapse. Research shows that long-term drug abuse results in significant changes in brain function that persist long after an individual stops using drugs. It is most important to realize that the same is true of not just illegal substances but alcohol and tobacco as well.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.